Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Abbott NORTHAMPTON ... has achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment ...

Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...

Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.

It was during the 1920s when the development of Butyn, a butyl alcohol-based anesthetic, marked the beginning of Abbott's long, productive and ground-breaking involvement in the field of anesthesia.

Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning ...

Recent advancements in AF ablation have led to the development of the novel pulsed field ablation (PFA) and very High-Powered Short Duration (VHPSD) radiofrequency ablation. PFA utilizes electrical ...

National Rugby League respects and honours the Traditional Custodians of the land and pay our respects to their Elders past, present and future. We acknowledge the stories, traditions and living ...